These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9217695)

  • 1. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
    Tschen E; Elewski B; Gorsulowsky DC; Pariser DM
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 5. Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
    Syed TA; Maibach HI
    Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butenafine and superficial mycoses: current status.
    Singal A
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
    Uchida K; Kudoh M; Yamaguchi H
    Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
    Reyes BA; Beutner KR; Cullen SI; Rosen T; Shupack JL; Weinstein MB
    Int J Dermatol; 1998 Jun; 37(6):450-3. PubMed ID: 9646136
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical sertaconazole (ertaczo)--another azole for tinea pedis.
    Med Lett Drugs Ther; 2004 Jun; 46(1185):50-1. PubMed ID: 15211288
    [No Abstract]   [Full Text] [Related]  

  • 10. Butenafine: an update of its use in superficial mycoses.
    Gupta AK
    Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A
    J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
    Tanuma H; Doi M; Ohta Y; Abe M; Kume H; Mukai H; Katsuoka K
    Mycoses; 2001; 44(7-8):287-99. PubMed ID: 11714064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A; Pandhi D; Agrawal S; Das S
    J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent.
    Greer DL; Weiss J; Rodriguez DA; Hebert AA; Swinehart JM
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):231-5. PubMed ID: 9270509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M; Schoellmann C; Korting HC
    Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantivity of topically applied antifungals on dermatophytic toe webs.
    del Rio E
    Cutis; 2001 May; 67(5 Suppl):40-1. PubMed ID: 11398270
    [No Abstract]   [Full Text] [Related]  

  • 19. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.